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caring. It provided direct payments and aid to allow carers to take a break from caring 
(with or without the person cared for). Here we investigate the effects of the scheme 
on carers’ HRQL. Methods: In order to conduct the evaluation, a quality of life survey 
was conducted. Carers were asked to complete questionnaires at Week 0 and Week 
12. One of the questionnaires selected for inclusion in both surveys was the EQ-5D 
(5 level). Results: Of the 155 patients completing the Week 0 survey, 97 completed 
at least some of the Week 12 survey. There was some evidence to suggest a small 
improvement in HRQL via the EQ-5D-5L (0.62 to 0.66, n= 86). Both pre- and post-inter-
vention the estimated mean utility of the cohort was significantly lower than 0.81; 
the value that would be predicted in the general population given the age and gender 
characteristics of the cohort. ConClusions: Informal carers have significantly lower 
HRQL than age-matched controls. While it is not possible to draw firm conclusions 
around the benefit derived from the intervention, due to the lack of control arm, the 
evaluation of a carer breaks service indicates a potentially modest benefit.
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objeCtives: To understand social and work impacts of caring for children/
adolescents with attention-deficit/hyperactivity disorder (ADHD) in Sweden 
relative to a combined cohort of other Nordic countries (Denmark, Finland and 
Norway). Methods: Carers in Sweden and other Nordic countries completed the 
Caregiver Perspective of Pediatric ADHD (CAPPA) online survey capturing carer 
impacts, including work, social activities and family relationships, due to their 
child’s ADHD. Impacts were explored when the child was “on” and “off” medica-
tion (e. g. days medication not taken). Comparisons of “on” and “off” medication 
were examined using the Wilcoxon Signed-Rank test. No statistical comparisons of 
impacts were made between countries. Results: 219 Swedish and 249 other Nordic 
carers of ADHD children aged 6–17 years completed the survey. 37% of Swedish 
carers reported employment changes (e. g. resigned, changed shift, reduced hours) 
due to their child’s ADHD; 52% of these changes occurred when the child was “on” 
medication. In the past 4 weeks, 60% of Swedish carers reported missing work and 
45% reported being late for work. After excluding outliers (n= 15), mean number 
of hours missed was 4.32 (n= 91, SD 2.53) and mean number of times late was 2.91 
(n= 69, SD 1.35). Swedish carers reported fewer “moderate” to “tremendous” impacts 
on social life when their child was “on” versus “off” medication (partner relationship 
strain: 37% vs 67%; relationship strain with other children: 29% vs 57%; social activity 
interference: 40% vs 59%). Relative to other Nordic countries, more Swedish carers 
reported being late for work (36% vs 45%) and more “moderate” to “tremendous” 
interference with social activities while the child was medicated (29% vs 40%). All 
other impacts described were similar between the two cohorts. ConClusions: 
While medication helped, it did not completely alleviate child ADHD-related impacts 
on work and social activities among carers from Sweden and other Nordic countries.
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objeCtives: Clinically relevant anxiety is a highly prevalent co-morbidity in chronic 
obstructive pulmonary disease (COPD), affecting up to 74% of patients. However, 
despite its prevalence, co-morbid anxiety remains under-recognised and under-
managed. Furthermore, its identification and measurement can be confounded by 
the overlap of somatic symptoms between anxiety and COPD. This study sought to 
evaluate the ability of existing patient-reported outcome (PRO) measures to assess 
anxiety in COPD through conceptual mapping, with particular attention on the 
coverage of non-somatic anxiety symptoms. Methods: To determine conceptual 
comprehensiveness, the content of 12 extant anxiety PROs was mapped to a concep-
tual model of anxiety in COPD, developed through a qualitative literature review and 
in-depth qualitative interviews (n= 15) of COPD patients with anxious symptomol-
ogy. Results: The conceptual model contained 29 concepts within five domains 
(somatic [15 concepts]; psychic tension [5 concepts]; apprehension [5 concepts]; 
panic [3 concepts]; behavioural [1 concept]). The most comprehensive conceptual 
coverage was found in the Mind Over Mood Anxiety Inventory which assesses 18/29 
(62%) concepts across all five domains. Concept mapping revealed the majority of 
PROs are biased toward assessing somatic symptoms of anxiety, with no measure 
providing comprehensive assessment of non-somatic concepts. Indeed, the two 
most widely used anxiety PROs in COPD research and clinical practice (Beck Anxiety 
Inventory [BAI] and Hospital Anxiety and Depression Scale) provide sub-optimal cov-
erage of anxiety concepts. In particular, the BAI is heavily weighted toward assessing 
somatic concepts, with little focus on psychic, apprehensive, panic and behavioural 
concepts of anxiety. ConClusions: In light of the sub-optimal content validity of 
extant instruments, including those commonly used in research and practice, there 
is a need for a comprehensive COPD-specific anxiety PRO. Such an instrument can 
be utilised in clinical trials for evaluating new products and enhance the accuracy 
of anxiety screening and measurement in clinical practice.
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objeCtives: The Anxiety Inventory for Respiratory disease (AIR) is a novel, non-
somatic patient-reported outcome (PRO) measure of anxiety among patients with 
chronic obstructive pulmonary disease (COPD). Traditional psychometric meth-
medicine. The study provides a baseline data for further studies on patients’ adher-
ence to psychotropic medications.
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objeCtives: Treatment continuation of 3 long acting, injectable, antipsychotic 
drugs: paliperidone palmitate, risperidone microspheres and haloperidol decanoate, 
was evaluated in the Belgian outpatient setting using panel data from public phar-
macies. Drug dosage, age distribution and frequency of co-prescribed antipsychotic 
medications were investigated. Methods: IMS LifelinkTM Treatment Dynamics 
database was used, applying appropriate selection criteria. Three patient cohorts 
that started paliperidone palmitate, risperidone microspheres or haloperidol 
decanoate treatment respectively, between 1 December 2011 and 31 August 2012, 
were analyzed. All cohorts included at least 13 months of follow up. Treatment 
continuation was investigated. Results: After 90 and 180 days, more patients 
continued treatment with paliperidone palmitate (60,71% and 42,41% respectively) 
than with risperidone microspheres (39, 07% and 26, 49%) or haloperidol decanoate 
(34,23% and 17,57%). Within 3 months after discontinuation, more patients restarted 
their treatment when using paliperidone palmitate (41%) compared to risperidone 
microspheres (27%) or haloperidol decanoate (17%). For all therapies, dosing was 
comparable between treatment initiation and discontinuation. Patients treated 
with paliperidone palmitate were generally younger (patients ≤ 32 years: paliperi-
done palmitate, 26%; risperidone microspheres, 17%; or haloperidol decanoate, 5%). 
Over 1 year, on average 62% of patients used paliperidone palmitate or risperidone 
microspheres in monotherapy. In contrast, haloperidol decanoate in monotherapy 
declined over time (from 49% to 28% in 1 year). Medication against extrapyramidal 
symptoms was on average more used with haloperidol decanoate (37%) than with 
paliperidone palmitate (16%) or risperidone microspheres (18%). ConClusions: 
Results of the database research indicate that more patients treated with paliperi-
done palmitate continued their therapy, restarted therapy and were of younger 
age than patients receiving risperidone microspheres or haloperidol decanoate. 
Monotherapy was more frequently observed with paliperidone palmitate and risp-
eridone microspheres while co-medication against extrapyramidal symptoms was 
less frequently used compared to with haloperidol decanoate.
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objeCtives: Research indicates schizophrenia is a cause of burden for patients and 
caregivers. This study examined health-related quality of life (HRQoL) and comor-
bidities experienced by schizophrenia caregivers compared to non-caregivers and 
caregivers of other conditions. Methods: Data were obtained from the 2010-2011 
and 2013 5E. U. (UK, Germany, France, Italy, Spain) National Health and Wellness 
Survey, an online questionnaire that’s representative of the total adult (18+ years) 
population. Respondents provided information on HRQoL (SF-36v2: mental and 
physical component summary (MCS, PCS) and SF-6D (health utility) scores), and 
comorbidities (sleep-difficulties, insomnia, pain, headaches, heartburn, anxiety, 
depression) experienced in the past 12 months. Schizophrenia caregivers (n= 398) 
were matched to non-caregivers (n= 158,989) and other caregivers (n= 14,341) on 
baseline characteristics (age, gender, income, etc.) via propensity scores (1:2). Chi-
square tests and ANOVAs were used to determine significant differences across the 
groups. Results: The average age of schizophrenia caregivers was 45.3 (SD= 15.8 
years), 59.6% were female, and 14.8% reported an income of € 50,000/£40,000+. After 
matching, schizophrenia caregivers reported significantly lower MCS (40.3 vs. 45.9), 
PCS (46.8 vs. 49.0) and health utilities (0.64 vs. 0.71), compared to non-caregivers (all 
p< 0.001). Schizophrenia caregivers reported experiencing significantly more sleep 
difficulties (42.7% vs. 28.5%), insomnia (32.4% vs. 18.5%), pain (39.7% vs. 30.4%), 
headaches (48.0% vs. 42.0%), heartburn (31.7% vs. 22.9%), anxiety (37.9% vs. 23.6%), 
and depression (29.4% vs. 19.4%) than non-caregivers. Comparing schizophrenia 
caregivers and other caregivers, schizophrenia caregivers reported lower MCS (40.3 
vs. 42.7, p< 0.001), and health utilities (0.64 vs. 0.67, p< 0.001). Schizophrenia caregiv-
ers reported significantly more sleep difficulties (42.7% vs. 36.8%), insomnia (32.4% 
vs. 26.0%), pain (39.7% vs. 31.5%), and anxiety (37.9% vs. 29.8%) than other caregiv-
ers. ConClusions: Schizophrenia caregivers reported worse HRQoL and more 
comorbidities than non-caregivers and caregivers of other conditions. Providing 
caregivers with support services to better manage patients effectively may improve 
caregiver’s health status.
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objeCtives: Informal carers are widely acknowledged to be an important part of 
health care provision, as well as a source of substantial cost savings to the health 
care system. It has been observed, however, that carers have worse health-related 
quality of life (HRQL) than the general population. As a result of this, the wellbeing 
of carers has been set as a government priority. In Bristol, UK, the National Health 
Service and council jointly funded a 12-week scheme to facilitate breaks from 
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objeCtives: Alcohol consumption carries a risk of adverse personal, social, 
and health effects. Alcohol use disorder (AUD) is a problematic pattern of alco-
hol use leading to clinically significant impairment or distress. The aim of this 
study was to determine the patient-perceived impact of AUD. Methods: Focus 
groups were conducted with a sample of patients with current or remitted AUD 
in the UK and France to identify key areas of impact from the patient perspective. 
The groups were audio-recorded and transcribed. Thematic analysis of the data 
was undertaken. Results: Ten focus groups were conducted with a total of 38 
patients (20 current AUD, 18 remitted AUD; 26 male, 12 female; age range 23-69 
years). All patients met the diagnostic criteria (Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition) for alcohol dependence. Patients character-
ised their relationship with alcohol as an ongoing battle for control. The cycle of 
consumption and dependence permeated most areas of patients’ lives, with often 
devastating consequences. Seven key areas of impact of AUD were identified: 
social and personal relationships; household, family and social activities; self-
care and personal safeguarding; emotional well-being; control over life, self and 
alcohol; financial and housing situation; and sleep disturbance. The impact 
of AUD continued even after patients stopped drinking; remitted patients 
described the ongoing battle to remain abstinent, and the lasting legacy of dam-
aged relationships and feelings of low self-worth. ConClusions: AUD has con-
siderable impact on many areas of patients’ lives, particularly relationships, and 
feelings of control and self-worth, which can continue even after abstinence has 
been achieved. From the patient perspective, drinking cessation or reduced con-
sumption may not be the most relevant outcome to determine treatment benefit. 
There is a clear need for measures that can quantify the humanistic outcomes 
associated with AUD.
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objeCtives: To compare Quality of Life (QOL) and societal costs in an ADHD popula-
tion to a control group representing the general population. Methods: An online 
cross-sectional retrospective study among parents of children with ADHD was 
conducted via Balans, a Dutch ADHD organization. Because of large differences in 
responder groups in the initial study, comparison with a control group was added 
to understand the impact of ADHD compared to the general population in greater 
detail. Therefore, a separate online research among parents of children without 
ADHD or any other chronic disease was performed. The control group was selected 
on the basis of pre-defined characteristics in order to match the ADHD group. QoL 
(EQ-5D for children and parents and KIDSCREEN-10 for children) and societal costs 
(TiC-P) were surveyed based on proxy reporting. In this study, monthly resource 
use of patients and their parents was identified. Descriptive statistics, independent 
samples t-test and Chi-square for p-values (sig. 2-tailed) were used for analysis on 
significance in differences between samples. Results: The ADHD sample (n= 618) 
was compared to the control group (n= 704). Both groups primarily contained boys 
with a mean age of 11 years. QOL differed significantly between children with 
ADHD and the control group, both for EQ-5D (ADHD 0.80 vs. controls 0.96; p< 0.000) 
and KIDSCREEN-10 (ADHD 41.67 vs. controls 55.46; p< 0.000). The same is true for 
their parents (ADHD 0.83 vs. controls 0.88; p< 0.000). Total monthly costs associated 
with ADHD differed significantly as well, both for children (ADHD € 518 vs. controls 
€ 91; p< 0.000) and parents (ADHD € 288 vs. controls € 49; p< 0.000). ConClusions: 
Although this was not a direct comparative study, the magnitude of differences in 
absolute results seem to justify the conclusion that ADHD accounts for significantly 
higher costs and lower QoL for patients, parents and society compared to a control 
group representing the general population.
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objeCtives: The purpose of this study, carried out on a general sample in France in 
2013, was to measure the burden of alcohol consumption on the entourage (family 
members and friends) of people with alcohol problems and to identify the con-
sequences of excessive alcohol consumption on the caregivers. Methods: The 
ENTOURAGE survey was conducted among individuals from KANTAR HEALTH’s 
panel. A self-administered questionnaire was sent to a representative sample 
of 10,000 adults (aged 18+) based on the quota method. The level of burden was 
assessed using the Zarit Burden Scale (ZBI) and the level of alcohol consumption 
using the AUDIT-C. Results: Of the 7,813 individuals who filled out their question-
naires, 13% (n= 1,018) stated that a member of their entourage has a problem with 
alcohol. Of this 13%, the alcohol consumption level was ‘not at risk’ in 2% (n= 18), 
‘excessive’ in 39% (n= 406) and 52% (n= 533) were ‘alcohol-dependent’ according 
to AUDIT-C scores; 7% did not specify the quantity of alcohol consumed. 37.0% 
of these 1,018 respondents rated burden as ‘minimal’, 40.7% as ‘mild’, 18.3% as 
‘moderate’ and 3.9% considered it as ‘severe’. The average score of the ZBI was 28.5 
ods have demonstrated promising properties of the tool. However, traditional 
psychometrics may have clinically relevant limitations, including scale and sam-
pling dependency. The objective of this study was to evaluate the AIR’s strengths 
and weaknesses using more sophisticated Rasch Measurement Theory (RMT) 
Methods. Methods: Previously collected data from an observational study of 56 
patients with COPD (mean age 70 years, 52% female) were analysed using RMT 
(conducted using RUMM2030 software) to evaluate scale-to-sample targeting, meas-
urement adequacy and person reliability. Results: Person severity was well spread 
(-5.47 to 2.01 logits) but there was evidence of sample-to-scale mis-targeting at the 
lower end of the anxiety severity spectrum. Monotonic ordering of response catego-
ries for all 10 items suggest that the response options work as expected. No evidence 
of misfit on any of the items was identified (fit residual range -0.85 to 2.28) and this 
was supported by item characteristic curves, which demonstrated good fit to the 
Rasch model. Correlations among item residuals identified 11 item pairs which 
exceeded recommended values (-0.30 to 0.30) indicating local dependency (range 
-0.48 to 0.31). The AIR had a good person separation index (0.90) indicating that 
the sample were well separated by the instrument. ConClusions: RMT analysis 
demonstrated that the AIR has promising measurement properties. Mis-targeting at 
the lower end of the severity spectrum is of minimal concern given the mild severity 
of anxiety symptoms in this sample. Any modifications to address this issue should 
be carefully considered in light of the excellent screening properties previously 
identified. Evidence of local dependency between some items can be explored by 
reviewing qualitative data used in the development of the AIR.
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objeCtives: To study the impact of patients with depressive disorder on quality of 
life and factors predicting quality of life in depressive disorders patients. Methods: 
This is a cross-sectional survey research. The sample consisted of depressive disor-
der patients, having depressive disorder diagnosed by psychiatrists using standard 
criteria of DSM-IV during January - July 2012 and aged 18 years and above, approxi-
mately 400 participants were selected using quota sampling method. The instru-
ments used in this study were questionnaires on SF-36 Health Survey. Comparative 
analysis of average multiple regression analysis imported variables stepwise, par-
tial correlation and colinearity statistics. Results: The number of patients with 
major depressive disorder found that respondents were 397 people. Quality of life 
of depressive disorder patients in 8 scales found that physical function (mean 67.9) 
role limited by physical problems (mean 40.4) role limited by emotional problems 
(mean 38.0) bodily pain (mean 66.6) vitality (mean 48.5), mental health (mean 53.7) 
social-functioning (mean 65.6) general health (mean 47.8) and female who had expe-
rienced to be depressive disorder shown score in quality of life lower than male in 
Physical Function (t= 3.608, p< 0.000). A multiple regression analysis, the independent 
variables by stepwise analysis found the equation that predicts the optimal quality 
of life consists of 6 independent variable were the severity of symptoms, age, marital 
status, unemployed widower, primary school and female which is related to the 
quality of life of patients with depression is high (R = 0.706) could explain the change 
in quality of life was 49.8 percent. ConClusions: Quality of life in depressive disor-
der Thai patients is lower than that of general population. Increased unemployment 
and marital divorce will negatively affect the quality of life of depressive disorder 
patients. Therefore care depressive disorder patients in addition to medical treat-
ment should pay attention to the social economy of the patient.
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objeCtives: The Alcohol Quality of Life Scale (AQoLS) is a new measure to assess 
health-related quality of life (HRQL) in alcohol use disorder (AUD). The measure, 
developed in the UK and France, has 34 items over 7 hypothesised domains: rela-
tionships, activities, looking after self, emotional impact, control, living conditions, 
and sleep. The aim of this study was to adapt the measure for use in Japan, China 
and South Korea. Methods: The cultural adaptation process included three stages: 
initial translation of the UK-English AQoLS using forward-back translation; lay 
assessment of the initial translations with members of the general population in 
the target countries to ensure cultural appropriateness of the language register and 
content; cognitive debriefing interviews with AUD patients in the target countries 
to assess face and content validity. Results: Initial translations of the AQoLS into 
the three target languages were produced. Lay assessments were conducted with 
8 individuals in Japan, 5 in China, and 5 in Korea, and modifications made to each 
new language version. Cognitive debriefing interviews were conducted with 8 AUD 
patients in Japan (3 male, age 34-71 years), 10 in China (8 male, age 25-45 years), and 
12 in Korea (9 male, age 44-65 years). Patients found the AQoLS easy to understand 
and relevant to their experiences. Further modifications were made to maintain 
consistency with the source version, clarify the intended meaning, or to improve 
acceptability of individual word or phrases. ConClusions: The new adaptations 
of the AQoLS are appropriate instruments to assess HRQL in AUD patients in Japan, 
China, and Korea. The adaptation methodology was comprehensive, involving trans-
lation experts, members of the general public, and patients with AUD in each target 
country. This ensured that the new language versions were conceptually equivalent 
to the source instrument and appropriate to the target culture.
